<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412023001100814</article-id>
<article-id pub-id-type="doi">10.24245/gom.v91i11.8779</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Enfermedad inflamatoria intestinal en el embarazo: peculiaridades y tratamiento. Revisión bibliográfica]]></article-title>
<article-title xml:lang="en"><![CDATA[Inflammatory bowel disease in pregnancy: peculiarities and treatment. Review.]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lozano Vidal]]></surname>
<given-names><![CDATA[Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Durán Castellanos]]></surname>
<given-names><![CDATA[Isabel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gómez Ortiz]]></surname>
<given-names><![CDATA[Carla]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Carmona Domínguez]]></surname>
<given-names><![CDATA[Eva]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario Virgen Macarena  ]]></institution>
<addr-line><![CDATA[Sevilla ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>91</volume>
<numero>11</numero>
<fpage>814</fpage>
<lpage>822</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412023001100814&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412023001100814&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412023001100814&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  ANTECEDENTES: La prevalencia de la enfermedad inflamatoria intestinal en países occidentales se estima en 0.7%. Su relación con el embarazo está en constante estudio y actualización. Esta enfermedad se relaciona con diferentes afecciones obstétricas: prematurez y aumento de teratogenia. La atención médica y el tratamiento suponen un reto durante el embarazo.  OBJETIVO: Actualizar los conocimientos acerca de cómo el embarazo modifica el curso de la enfermedad y cómo la enfermedad modifica el curso de aquél, mencionar la seguridad de los tratamientos a las embarazadas y los consensos obstétricos vigentes.  METODOLOGÍA: Revisión bibliográfica efectuada en dos bases de datos (PubMed y Embase) con los siguientes criterios de búsqueda (MeSH): &#8220;inflammatory bowel disease&#8217;&#8217; y &#8220;pregnancy&#8217;&#8217; de artículos publicados entre el 2015 y diciembre del 2022, escritos en todas las lenguas: metanálisis, ensayos clínicos, revisiones sistemáticas, narrativas, estudios prospectivos y retrospectivos.  RESULTADOS: Se identificaron 345 registros, que luego de la eliminación de los duplicados y otras causas se seleccionaron 30 artículos por su relevancia y novedad.  CONCLUSIÓN: La paciente con enfermedad inflamatoria intestinal, en estado de embarazo, debe considerarse de alto riesgo y requerimiento de seguimiento estrecho. La planificación del embarazo es decisiva a fin de optimizar el grado de actividad de la enfermedad y aminorar sus complicaciones. Si bien la mayor parte de los fármacos para su tratamiento se consideran seguros es necesario conocerlos en profundidad.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  BACKGROUND: The prevalence of inflammatory bowel disease is estimated to be 0.7% in western countries. Its association with pregnancy is constantly being studied and updated. This disease is associated with several obstetric conditions: prematurity or increased teratogenicity. Medical care and treatment during pregnancy is a challenge.  OBJECTIVE: To update the knowledge on how pregnancy modifies the course of the disease and how the disease modifies the course of the disease, to mention the safety of treatments for pregnant women and the current obstetric consensus.  METHOD: Literature search in two databases (PubMed and Embase) with the following search criteria (MeSH): "inflammatory bowel disease" and "pregnancy" of articles published between 2015 and December 2022, written in all languages: meta-analyses, clinical trials, systematic reviews, narratives, prospective and retrospective studies.  RESULTS: 345 records were identified and, after elimination of duplicates and other causes, 30 articles were selected for relevance and novelty.  CONCLUSION: The pregnant patient with inflammatory bowel disease should be considered high risk and require close follow-up. Pregnancy planning is essential to optimise disease activity and minimise complications. Although most drugs used to treat inflammatory bowel disease.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Embarazo]]></kwd>
<kwd lng="es"><![CDATA[embarazadas]]></kwd>
<kwd lng="es"><![CDATA[enfermedad inflamatoria intestinal]]></kwd>
<kwd lng="es"><![CDATA[complicaciones]]></kwd>
<kwd lng="es"><![CDATA[prevalencia]]></kwd>
<kwd lng="en"><![CDATA[Pregnancy]]></kwd>
<kwd lng="en"><![CDATA[Pregnant women]]></kwd>
<kwd lng="en"><![CDATA[Inflammatory bowel disease]]></kwd>
<kwd lng="en"><![CDATA[Complications]]></kwd>
<kwd lng="en"><![CDATA[Prevalence]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Coward]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Clement]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Benchimol]]></surname>
<given-names><![CDATA[EI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Past and future burden of inflammatory bowel diseases based on modeling of population-based data]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>2019</year>
<volume>156</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1345-53.e4</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chouraki]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Savoye]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Dauchet]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The changing pattern of Crohn&#8217;s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007)]]></article-title>
<source><![CDATA[Aliment Pharmacol Ther]]></source>
<year>2011</year>
<volume>33</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1133-42</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cornish]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Teare]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A meta-analysis on the influence of inflammatory bowel disease on pregnancy]]></article-title>
<source><![CDATA[Gut]]></source>
<year>2007</year>
<volume>56</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>830-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carbery]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ghorayeb]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Madill]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Selinger]]></surname>
<given-names><![CDATA[CP.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pregnancy and inflammatory bowel disease: Do we provide enough patient education? A British study of 1324 women]]></article-title>
<source><![CDATA[World J Gastroenterol]]></source>
<year>2016</year>
<volume>22</volume>
<numero>36</numero>
<issue>36</issue>
<page-range>8219</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[van der Woude]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ardizzone]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bengtson]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease]]></article-title>
<source><![CDATA[J Crohn&#8217;s Colitis]]></source>
<year>2015</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>107-24</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hosseini-Carroll]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mutyala]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Seth]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management]]></article-title>
<source><![CDATA[World J Gastrointest Pharmacol Ther]]></source>
<year>2015</year>
<volume>6</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>156</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[YH]]></given-names>
</name>
<name>
<surname><![CDATA[Chun]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[J Crohns Colitis]]></source>
<year>2021</year>
<volume>15</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>719-32</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McConnell]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Mahadevan]]></surname>
<given-names><![CDATA[U.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pregnancy and the patient with inflammatory bowel disease: fertility, treatment, delivery, and complications]]></article-title>
<source><![CDATA[Gastroenterol Clin North Am]]></source>
<year>2016</year>
<volume>45</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>285-301</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa]]></surname>
<given-names><![CDATA[RV]]></given-names>
</name>
<name>
<surname><![CDATA[Simões]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Correia]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammatory bowel disease and pregnancy: is it a marker for adverse outcomes?]]></article-title>
<source><![CDATA[Rev Bras Ginecol E Obstet]]></source>
<year>2022</year>
<volume>44</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>915</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoekstra]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Van Roon]]></surname>
<given-names><![CDATA[AHC]]></given-names>
</name>
<name>
<surname><![CDATA[Bekkering]]></surname>
<given-names><![CDATA[FC]]></given-names>
</name>
<name>
<surname><![CDATA[Van Tilburg]]></surname>
<given-names><![CDATA[AJP]]></given-names>
</name>
<name>
<surname><![CDATA[West]]></surname>
<given-names><![CDATA[RL.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Decision making and outcome of pregnancies in female patients with inflammatory bowel disease: findings from a community-based practice]]></article-title>
<source><![CDATA[Eur J Gastroenterol Hepatol]]></source>
<year>2018</year>
<volume>30</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>704-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giessen]]></surname>
<given-names><![CDATA[J van der]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[VW]]></given-names>
</name>
<name>
<surname><![CDATA[Woude]]></surname>
<given-names><![CDATA[CJ van der]]></given-names>
</name>
<name>
<surname><![CDATA[Fuhler]]></surname>
<given-names><![CDATA[GM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Modulatory effects of pregnancy on inflammatory bowel disease]]></article-title>
<source><![CDATA[Clin Transl Gastroenterol]]></source>
<year>2019</year>
<volume>10</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pedersen]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Bortoli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Duricova]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women]]></article-title>
<source><![CDATA[Aliment Pharmacol Ther]]></source>
<year>2013</year>
<volume>38</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>501-12</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malhi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Tandon]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Perlmutter]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk Factors for postpartum disease activity in women with inflammatory bowel disease: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Inflamm Bowel Dis]]></source>
<year>2022</year>
<volume>28</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Watanabe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Nagahori]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fujii]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Non-adherence to medications in pregnant ulcerative colitis patients contributes to disease flares and adverse pregnancy outcomes]]></article-title>
<source><![CDATA[Dig Dis Sci]]></source>
<year>2021</year>
<volume>66</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>577-86</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Choden]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Mandaliya]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Charabaty]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mattar]]></surname>
<given-names><![CDATA[MC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Monitoring inflammatory bowel disease during pregnancy: Current literature and future challenges]]></article-title>
<source><![CDATA[World J Gastrointest Pharmacol Ther]]></source>
<year>2018</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De]]></surname>
<given-names><![CDATA[Voogd F]]></given-names>
</name>
<name>
<surname><![CDATA[Joshi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Van]]></surname>
<given-names><![CDATA[Wassenaer E]]></given-names>
</name>
<name>
<surname><![CDATA[Bots]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[D&#8217;Haens]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gecse]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intestinal ultrasound to evaluate treatment response during pregnancy in patients with inflammatory bowel disease]]></article-title>
<source><![CDATA[Inflamm Bowel Dis]]></source>
<year>2022</year>
<volume>28</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1045</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Killeen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gunn]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hartley]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Surgical management of complicated and medically refractory inflammatory bowel disease during pregnancy]]></article-title>
<source><![CDATA[Color Dis]]></source>
<year>2017</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>123-38</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nuñez]]></surname>
<given-names><![CDATA[F. P]]></given-names>
</name>
<name>
<surname><![CDATA[Quera]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sepúlveda]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pregnancy in inflammatory bowel disease: experience of a chilean cohort]]></article-title>
<source><![CDATA[Gastroenterol Hepatol]]></source>
<year>2021</year>
<volume>44</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>277-85</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsuda]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sameshima]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sekine]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study]]></article-title>
<source><![CDATA[Mod Rheumatol]]></source>
<year>2020</year>
<volume>30</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>852-61</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O&#8217;Toole]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Nwanne]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Tomlinson]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inflammatory bowel disease increases risk of adverse pregnancy outcomes: a meta-analysis]]></article-title>
<source><![CDATA[Dig Dis Sci]]></source>
<year>2015</year>
<volume>60</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>2750-61</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Crowe]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Seow]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of surgical therapies for inflammatory bowel disease on female fertility]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2019</year>
<volume>2019</volume>
<numero>7</numero>
<issue>7</issue>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foulon]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dupas]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Sabbagh]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review]]></article-title>
<source><![CDATA[Inflamm Bowel Dis]]></source>
<year>2017</year>
<volume>23</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>712-20</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ananthakrishnan]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cagan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mode of child-birth and long-term outcomes in women with inflammatory bowel diseases]]></article-title>
<source><![CDATA[Dig Dis Sci]]></source>
<year>2015</year>
<volume>60</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>471</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mozaffari]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Abdolghaffari]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Nikfar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Abdollahi]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: A systematic review with meta-analysis]]></article-title>
<source><![CDATA[Hum Exp Toxicol]]></source>
<year>2015</year>
<volume>34</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>445-59</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahadevan]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Long]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Kane S]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease]]></article-title>
<source><![CDATA[Gastroenterology]]></source>
<year>2021</year>
<volume>160</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1131-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bortlik]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Machkova]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Duricova]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-&#945; therapy during pregnancy: three-center study]]></article-title>
<source><![CDATA[Scand J Gastroenterol]]></source>
<year>2013</year>
<volume>48</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>951-8</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[OH]]></given-names>
</name>
<name>
<surname><![CDATA[Gubatan]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Juhl]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Streett]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Maxwell]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Clin Gastroenterol Hepatol]]></source>
<year>2022</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>74-87.e3</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gubatan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nielsen]]></surname>
<given-names><![CDATA[OH]]></given-names>
</name>
<name>
<surname><![CDATA[Levitte]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biologics during pregnancy in women with inflammatory bowel disease and risk of infantile infections: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>2021</year>
<volume>116</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>243-53</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cortes]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Borrás-Blasco]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Antequera]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ustekinumab therapy for Crohn&#8217;s disease during pregnancy: a case report and review of the literature]]></article-title>
<source><![CDATA[J Clin Pharm Ther]]></source>
<year>2017</year>
<volume>42</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>234-6</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="">
<source><![CDATA[Immune Modulating Therapies in Pregnancy and Lactation | ACOG]]></source>
<year></year>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
